Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
Elizabeth Allen(VIB-KU Leuven Center for Cancer Biology), Gabriele Bergers(Brigham and Women's Hospital)
Cited by 782
Related Papers
HIF1α Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion
|Cancer Cell|2008|1.1k
Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop
|Cancer Cell|2022|147
Targeting the tumour vasculature: from vessel destruction to promotion
|Nature reviews. Cancer|2024|133